Table 1.
PATH (N=15) | ST (N=15) | ||||
---|---|---|---|---|---|
N | Perc (%) | N | Perc (%) | Fisher's Exact (p) | |
Gender | 1.00 | ||||
Female | 10 | 66.67 | 11 | 73.33 | |
Race and Ethnicity | 1.00 | ||||
Caucasian-Non-Hispanic | 11 | 73.33 | 11 | 73.33 | |
African-American | 4 | 26.67 | 4 | 26.67 | |
Probable or Definite | 1.00 | ||||
Dementia | 4 | 26.67 | 3 | 20.00 | |
On Antidepressants | 12 | 78.7 | 12 | 78.7 | 1.00 |
Mann-Whitney Wilcoxon |
||||||||
---|---|---|---|---|---|---|---|---|
Mean | SD | Range | Mean | SD | Range | z | p | |
Age | 80.46 | 8.45 | 66–92 | 78.36 | 8.12 | 69–94 | −0.64 | 0.53 |
Education (years) | 12.50 | 3.67 | 6–18 | 12.23 | 2.68 | 6–16 | −0.25 | 0.80 |
BASELINE | ||||||||
HAM-D-24 Total1 | 22.40 | 3.92 | 17–28 | 21.40 | 2.80 | 17–26 | −0.52 | 0.60 |
MMSE Total2 | 26.86 | 2.33 | 20–30 | 26.40 | 2.95 | 19–29 | −0.15 | 0.88 |
Executive Dysfunction | ||||||||
DRS IP3 | 28.14 | 6.39 | 9–35 | 26.00 | 6.51 | 11–35 | −1.12 | 0.26 |
Stroop CW4 | 15.91 | 8.93 | 4–30 | 15.14 | 8.76 | 5–35 | 0.22 | 0.83 |
Memory-HVLT 5 | ||||||||
Immediate Recall | 3.27 | 1.91 | 0–6 | 3.87 | 1.46 | 1–6 | 0.86 | 0.39 |
Delayed Recall | 4.40 | 2.72 | 0–10 | 5.40 | 2.38 | 0–9 | 1.33 | 0.18 |
Charlson Total6 | 2.20 | 2.18 | 0–7 | 3.26 | 3.08 | 0–11 | 1.55 | 0.12 |
SDS Total7 | 13.73 | 5.64 | 0–20 | 10.43 | 5.02 | 0–20 | −1.76 | 0.08 |
MAI IADL8 | 17.17 | 4.37 | 10–25 | 17.36 | 4.47 | 11–26 | −0.10 | 0.92 |
Intensity of Antidepressant | ||||||||
Medication Treatment9 | 2.46 | 1.55 | 0–4 | 2.71 | 1.54 | 0–4 | 0.43 | 0.66 |
24-item Hamilton Depression Rating Scale
Mini Mental State Exam
Mattis Dementia Rating Scale – Initiation / Perseveration Subscale
Stroop Color-Word Score
Hopkins Verbal Learning Test – Revised
Charlson Commorbity Index
Sheehan Disability Scale Total = Social Life Score + Family Life/Home Responsibilities Score
Philadelphia Multilevel Assessment Instrument – Instrumental Activities of Daily Living (IADL) Subscale
Composite Antidepressant Score (CAD)